Detailed Results from the FIDELIO-DKD study

Ahead of the Virtual Media Briefing on 26th October, here you can find materials relevant to Professor Rajiv Agarwal's session on the FIDELIO-DKD study results.

Unmet Needs in the Treatment of Patients with CKD and T2D

Ahead of the Virtual Media Briefing on 26th October, here you can find materials relevant to Kerry Willis' session on the current unmet need in the treatment of patients with chronic kidney disease (CKD) and type 2 diabetes (T2D).  

Bayer’s Commitment to Research in Cardiovascular and Kidney Diseases

Ahead of the Virtual Media Briefing on 26th October, here you can find materials relevant to Richard Nkulikiyinka's session on Bayer's commitment to research in cardiovascular and kidney diseases.

Virtual Media Briefing Information

Ahead of the Virtual Media Briefing on 26th October, here you can find the  full agenda and corresponding speaker biographies.

Bayer in Cardiovascular Disease: Today & Tomorrow

Ahead of the live event on 24th August, here you can find a biography for Dr. Frank Misselwitz.

Atrial Fibrillation Media Resource Library

Atrial fibrillation (AF) is a heart rhythm problem which can lead to a…

More

Bayer’s Rivaroxaban Demonstrated Superior Protection Against…

Not intended for U.S. and UK Media New Late-Breaking Study Data…

More

Bayer’s Xarelto® Significantly Lowered the Combined Risk of Stroke,…

Not intended for U.S. or UK media Data from COMPASS study, including 27…

More

Bayer’s Xarelto® Significantly Reduced Bleeding Compared to VKA in AF…

Not intended for U.S. and UK Media New Study Presented at American…

More

Cancer-Associated Thrombosis Media Resource Library

Patients with cancer are at increased risk of developing a blood clot,…

More

Chronic Kidney Disease in Type 2 Diabetes: A Specific Approach to…

Ahead of the live event on 24th August, here you can find videos and…

More